Unknown Sites

Advanced Cardiovascular Magnetic Resonance for Detection of Programmed Cell Death Protein-1 Deficient Myocarditis

Volunteers
Health Professionals

What is the purpose of this trial?

We hypothesize that advanced CMR can detect myocardial structural, functional, and metabolic changes associated with autoimmune myocarditis in cardio-toxicity associated with CPI therapy of the PD-1 pathway in cancer patients. We propose to do this by applying advanced CMR methods for edema and fibrosis to detect early inflammation and cardio-toxicity in patients receiving CPI therapy.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Donna McMahon

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Lauren A. Baldassarre, MD, FACC
Associate Professor of Medicine (Cardiovascular Medicine); Vice Chief, Cardiovascular Medicine, Faculty Life, Cardiovascular Medicine; Cardiology Director of Cardiac MR/CT, Advanced Cardiovascular CT/MR Program; Director, Cardio-Oncology, Cardiovascular Medicine; Director, Cardio-Oncology Advanced Training Fellowship Program, Cardiovascular Medicine; Vice Chief of Diversity, Equity and Inclusion, Cardiovascular Medicine

Sub-Investigator

Harriet Kluger, MD

Last Updated
03/27/2024
Study HIC
#2000023943